Hyivy Health was created after founder Rachel Bartholomew’s recent fight with cervical cancer. She wanted to change the way 1 in 3 women worldwide who will experience a pelvic health complication in their lifetime are treated, given that the current standard of care is an over 84-year-old technology. Hyivy is creating the first data-driven pelvic rehabilitation system for the over 60 million women with hypertonic, painful pelvic floor conditions. Hyivy is currently raising a seed round of $2 million to have a FDA and Health Canada cleared, clinically validated and commercial ready product for 2023.

Hyivy Health logo



Event details

Date: September 21 - 23, 2022

Event contact

Patricia Cosgrove
Area Director
USA: Life Sciences


10 in total